Literature DB >> 1969784

Effects of antacids on the clinical pharmacokinetics of drugs. An update.

R Gugler1, H Allgayer.   

Abstract

Since a previous review by Hurwitz was published in 1977 a large number of reports on drug interactions with antacids have appeared, few of which are of clinical relevance. Tetracyclines form insoluble complex molecules by metal ion chelation with various antacids; tetracycline absorption may be decreased by more than 90% by this interaction. Of the new class of quinolone antibiotics, the absorption of ciprofloxacin and ofloxacin is reduced by 50 to 90% in the presence of aluminium- and magnesium hydroxide-containing antacids. In contrast to early work showing inhibition of the absorption of beta-adrenergic blocking drugs by antacids, subsequent studies did not confirm a reduction in the bioavailability of either atenolol or propranolol during antacid treatment; indeed, they showed an increase in the plasma concentrations of metoprolol when the drug was coadministered with an antacid. The bioavailability of captopril was significantly reduced in the presence of an antacid, and lower plasma concentrations of this angiotensin-converting enzyme inhibitor were accompanied by a reduction of its effect on the systolic blood pressure of the patients. The absorption of the cardiac glycosides digoxin and digitoxin is not inhibited by antacids to a significant degree, although earlier studies had shown a positive effect when the dissolution of the glycoside preparations was relatively poor. Antacids reduce the bioavailability of the H2-receptor antagonists cimetidine and ranitidine only when high antacid doses are used and when the drugs are administered simultaneously. The bioavailability of famotidine was not significantly altered by a potent antacid preparation, although a trend towards reduced absorption was observed. Iron absorption is significantly decreased in the presence of sodium bicarbonate and calcium carbonate, but is nearly complete when coadministered with aluminium-magnesium hydroxide. Nonsteroidal anti-inflammatory drugs such as naproxen, tenoxicam, ketoprofen, ibuprofen and piroxicam are not affected in their absorption by antacid treatment. Theophylline bioavailability is unchanged when the drug is given together with antacids, although its rate of absorption may be altered, leading to a reduction or an increase in the time of the occurrence of peak plasma drug concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969784     DOI: 10.2165/00003088-199018030-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  50 in total

1.  Avidity of terramycin and aureomycin for metallic cations.

Authors:  A ALBERT
Journal:  Nature       Date:  1953-08-01       Impact factor: 49.962

2.  Reduced absorption of aureomycin caused by aluminum hydroxide gel.

Authors:  B A WAISBREN; J S HUECKEL
Journal:  Proc Soc Exp Biol Med       Date:  1950-01

3.  Effect of concomitant antacid administration on plasma cimetidine concentrations during repetitive dosing.

Authors:  D W Shelly; P L Doering; W L Russell; R T Guild; L M Lopez; J Perrin
Journal:  Drug Intell Clin Pharm       Date:  1986-10

4.  Absorption and excretion of drugs. XXXVII. Effect of Ca2+ on the absorption of tetracycline from the small intestine. (2).

Authors:  K Kakemi; H Sezaki; M Hayashi; T Nadai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1968-11       Impact factor: 1.645

5.  Effect of food and various antacids on the absorption of tenoxicam.

Authors:  R O Day; S Lam; P Paull; D Wade
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

6.  Ciprofloxacin and antacids.

Authors:  L C Preheim; T A Cuevas; J S Roccaforte; M A Mellencamp; M J Bittner
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

7.  Antacids inhibit absorption of cimetidine.

Authors:  W M Steinberg; J H Lewis; D M Katz
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

8.  Effect of cimetidine and antacids on gastrointestinal absorption of tetracycline.

Authors:  M Garty; A Hurwitz
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

9.  [On the pharmacokinetics of tiaprofenic acid and its possible interactions with acetylsalicylic acid and aluminum hydroxide (author's transl)].

Authors:  N Marećek; P W Lücker; B Penth; P Altmayer; K Wetzelsberger
Journal:  Arzneimittelforschung       Date:  1981

10.  The effect of antacid and aspirin on the bioavailability of isofezolac in man.

Authors:  I Rocher; J F Henry; B Flouvat
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-09
View more
  28 in total

1.  Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.

Authors:  Gabriela Grunder; Yvonne Zysset-Aschmann; Florence Vollenweider; Thomas Maier; Stephan Krähenbühl; Juergen Drewe
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Detection of potential drug interactions - a model for a national pharmacy register.

Authors:  Bengt Astrand; Emelie Astrand; Karolina Antonov; Göran Petersson
Journal:  Eur J Clin Pharmacol       Date:  2006-07-29       Impact factor: 2.953

Review 4.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 5.  A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD.

Authors:  Thomas D Nolin
Journal:  Semin Dial       Date:  2015-04-08       Impact factor: 3.455

Review 6.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

7.  Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans.

Authors:  U Jaehde; F Sörgel; U Stephan; W Schunack
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

Review 8.  Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives.

Authors:  Thomas Unger; Elena Kaschina
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  The effects of magnesium hydroxide on the absorption and efficacy of two glibenclamide preparations.

Authors:  P J Neuvonen; K T Kivistö
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

10.  Lack of effect of magnesium-aluminium hydroxide on the absorption of theophylline given as a pH-dependent sustained release preparation.

Authors:  J F Muir; G Peiffer; M O Richard; D Benhamou; M Andrejak; L Hary; N Moore
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.